Leo Pharma Strengthens Dermatology Position With Second Eczema Win

 
• By Alaric DeArment
  
Leo announced positive topline Phase III results for its topical JAK inhibitor in chronic hand eczema • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D